Publication | Closed Access

Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics

Prognostic BiomarkersBreast OncologyEngineeringMedicineNext-generation SequencingPathologyCancer GenomicsBreast CancerCancer BiologyTriple-negative Breast CancerCancer GeneticsSystems BiologyOncologyRadiation OncologyMolecular DiagnosticsChd4-β1 Integrin AxisTumor Biology